The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
.
Recent Transactions
Sort By
30-Jun-21
Pending
Undisclosed
Target:
Deltalab
Acquiror:
SCG Packaging Public Company Limited
Advising Deltalab, a leading Spanish laboratory solutions provider with dedicated manufacturing capacity, on the sale of the company to SCG Packaging Public Company Limited, the largest integrated packaging and paper company in Southeast Asia
11-Jun-21
$248 million
Target:
My Alarm Center
Acquiror:
Ad Hoc Group of First Lien Lenders
Advised the Ad Hoc Group of First Lien Lenders on the pre-packaged Chapter 11 restructuring of My Alarm Center, a provider of security and smart home monitoring services
07-Jun-21
Undisclosed
Target:
Rights to General, Right Guard and Dry Idea brands
Acquiror:
N/A
Advised Henkel on its brand divestment program (including the sale of the General, Right Guard and Dry Idea brands)
03-Jun-21
Undisclosed
Target:
Le Petit Depot
Acquiror:
Phoon Huat
Advised Le Petit Depot, Singapore’s leading online platform specializing in the sale of European food products, on the sale of a controlling stake to, and strategic partnership with, Phoon Huat
01-Jun-21
Undisclosed
Target:
VEP Healthcare
Acquiror:
U.S. Acute Care Solutions
Advised VEP Healthcare, a leading, physician-owned provider of clinical management services in emergent and inpatient settings in the United States, on its merger with U.S. Acute Care Solutions
10-May-21
Pending
N/A
Target:
International Flavors & Fragrances, Inc.’s Fruit Preparations business
Acquiror:
Frulact Serviços Partilhados, SA
Advised International Flavors & Fragrances on the divestiture of its European-based Fruit Preparation business to Frulact Serviços Partilhados, SA
07-May-21
N/A
Target:
MindPath Care Centers
Acquiror:
Community Psychiatry
Advised Community Psychiatry, a leading provider of outpatient behavioral health services with a focus on high-quality clinically-driven care, on its acquisition of MindPath Care Centers, deepening its national presence to more than 350 providers across the US
31-Mar-21
Pending
~$1.1 billion
Target:
Procaps Group
Acquiror:
Union Acquisition Corp. II (NASDAQ: LATN)
Advising Procaps Group, a leading global pharmaceutical technology and healthcare company based in Colombia, on its merger with Union Acquisition Corp. II (NASDAQ: LATN), a special purpose acquisition company
31-Mar-21
$801 million
Target:
Assets of NPC International, a former national Wendy’s and Pizza Hut franchisee
Acquiror:
Flynn Restaurant Group and a consortium of existing Wendy’s franchisees
Advised the Company on its chapter 11 proceedings and $801mm sale through a § 363 process
18-Mar-21
$750 million
Target:
Canopy Growth Corporation
Acquiror:
King Street Capital Management, L.P.
Advised Canopy Growth, a leading diversified cannabis company, on its US$750 million term loan financing with King Street Capital Management, L.P.
26-Feb-21
Undisclosed
Target:
MDLIVE
Acquiror:
Cigna
Advising Cigna on the acquisition of MDLIVE, a virtual care delivery platform, by Evernorth, Cigna’s health services portfolio
25-Feb-21
$1.5 billion
Target:
Ascena Retail Group, Inc.
Acquiror:
Sycamore Partners
Advised the Ad Hoc Group of First-Lien Term Loan lenders of Ascena Retail Group, Inc. with respect to (i) negotiation of a restructuring support agreement, including a fully backstopped DIP and exit financing and (ii) a sale of Ann Taylor, LOFT and Lane Bryant as well as the intellectual property assets of the Justice and Catherine’s brands.
19-Feb-21
$33 million
Target:
Acacia Pharma Group plc
Acquiror:
N/A
Advised Acacia Pharma Group plc, a US headquartered commercial stage biopharmaceutical company incorporated in England and listed in Belgium, on its placing of 10m new ordinary shares at a price of €2.70 per share
09-Feb-21
Undisclosed
Target:
US Acute Care Solutions
Acquiror:
Apollo Hybrid Value Fund
Advising US Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on its recapitalization and buyout of minority partner, Welsh Carson
29-Dec-20
$110 million
Target:
Biogix, Inc.
Acquiror:
Alliance Pharma plc
Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc
13-Nov-20
$495 million
Target:
Libbey, Inc.
Acquiror:
N/A
Advised the Committee of Unsecured Creditors on the in-court restructuring of Libbey, Inc., a leading tableware manufacturer
13-Nov-20
$343 million
Target:
Revlon Consumer Products Corporation
Acquiror:
N/A
Advised Ad Hoc Group of Note Holders with respect to Revlon’s Exchange Offer
16-Oct-20
$430 million
Target:
Alert 360 (Central Security Group, Inc.)
Acquiror:
N/A
Advised the Ad Hoc Group of First Lien Lenders on the out-of-court restructuring of Alert 360 (Central Security Group, Inc.), a leading home-security provider
01-Oct-20
$1.05 billion
Target:
Akorn, Inc.
Acquiror:
First Lien Term Loan Lenders
Advised Ad Hoc Group of First Lien Term Loan Lenders on Akorn’s in-court recapitalization
30-Sep-20
$236 million
Target:
J. Jill, Inc.
Acquiror:
TowerBrook Capital Partners L.P.
Advised TowerBrook Capital Partners L.P., a leading investment management company and majority shareholder of J. Jill, on the comprehensive out-of-court recapitalization of J. Jill
15-Sep-20
$NA
Target:
Surgery Partners’ Anesthesia Services
Acquiror:
NorthStar Anesthesia
Advised Surgery Partners, a leading owner and operator of surgical facilities, on the divestiture of its anesthesia services business to NorthStar Anesthesia
12-Aug-20
$225 million
Target:
340B Link
Acquiror:
Omnicell
Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)
01-Jul-20
$225 million
Target:
Cello Health plc
Acquiror:
Arsenal Capital Partners
Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States
11-Jun-20
$760 million
Target:
CSM Bakery Solutions
Acquiror:
Rhône Group
Advised the Ad-Hoc Group of First Lien and Second Lien Lenders on consensual out-of-court amend & extend
10-Jun-20
$134 million
Target:
Equity stake in Bupa Arabia
Acquiror:
Bupa Ltd.
Advising Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, the largest health insurance provider in the Kingdom of Saudi Arabia